The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
PTN · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
HCSG · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | PTN | ECOR | HCSG | SRTS |
|---|---|---|---|---|
| Moat Score (0–100) | 47 (highest) | 47 (highest) | 47 (highest) | 47 (highest) |
| Methodology version | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 |
| Business trend | 20 | 65 (highest) | 45 | 54 |
| Pricing power | 95 (highest) | 70 | 24 | 90 |
| Returns on capital | — | 0 | — | 11 (highest) |
| Balance-sheet safety | 28 | 55 | 78 (highest) | 55 |
| Capital discipline | 44 (highest) | 44 (highest) | 41 | 24 |
| Price vs. high estimate | No price data | No price data | 227% above high estimate | Around the high estimate (largest discount to high estimate) |
| Market cap | $7.9M | $48.6M | $1.7B | $51.0M |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filings as of | FY2025 | FY2025 | FY2025 | FY2025 |